57
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Low-dose naloxone provides an abuse-deterrent effect to buprenorphine

, , &
Pages 791-798 | Published online: 04 Nov 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Walter Ling, Steve Shoptaw & David Goodman-Meza. (2019) Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation. Substance Abuse and Rehabilitation 10, pages 69-78.
Read now

Articles from other publishers (4)

Alice Bruneau, Clarice Poirier, Mélanie Bérubé, Aline Boulanger, Céline Gélinas, Line Guénette, Anaïs Lacasse, David Lussier, Yannick Tousignant-Laflamme, M. Gabrielle Pagé & Marc O. Martel. (2022) French-Canadian Translation and Cultural Adaptation of the Clinical Opiate Withdrawal Scale: The COWS-FC. The Canadian Journal of Psychiatry 67:9, pages 701-711.
Crossref
Martin Hale, Joseph Gimbel & Richard Rauck. (2020) Buprenorphine buccal film for chronic pain management. Pain Management 10:4, pages 213-223.
Crossref
Naveen K. Dhagudu, Atul Ambekar, Alok Agrawal, Ravindra Rao, Ashwani K. Mishra, Raka Jain & Shalini Singh. (2020) Is there enough naloxone to deter the diversion? Effect of concurrent administration of intravenous naloxone on opioid agonist effects of intravenous buprenorphine: A randomised, double‐blind, within‐subject, crossover study among opioid‐dependent subjects. Drug and Alcohol Review 39:5, pages 595-603.
Crossref
Richard J. Bodnar. (2017) Endogenous Opiates and Behavior: 2015. Peptides 88, pages 126-188.
Crossref